186 related articles for article (PubMed ID: 27871775)
1. Recombinant proteins of helminths with immunoregulatory properties and their possible therapeutic use.
Nascimento Santos L; Carvalho Pacheco LG; Silva Pinheiro C; Alcantara-Neves NM
Acta Trop; 2017 Feb; 166():202-211. PubMed ID: 27871775
[TBL] [Abstract][Full Text] [Related]
2. Schistosome Infection and Schistosome-Derived Products as Modulators for the Prevention and Alleviation of Immunological Disorders.
Mu Y; McManus DP; Hou N; Cai P
Front Immunol; 2021; 12():619776. PubMed ID: 33692793
[TBL] [Abstract][Full Text] [Related]
3. Lessons from helminth infections: ES-62 highlights new interventional approaches in rheumatoid arthritis.
Pineda MA; Al-Riyami L; Harnett W; Harnett MM
Clin Exp Immunol; 2014 Jul; 177(1):13-23. PubMed ID: 24666108
[TBL] [Abstract][Full Text] [Related]
4. Helminth-derived immunomodulatory molecules.
Adisakwattana P; Saunders SP; Nel HJ; Fallon PG
Adv Exp Med Biol; 2009; 666():95-107. PubMed ID: 20054978
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic potential of helminths in autoimmune diseases: helminth-derived immune-regulators and immune balance.
Wang M; Wu L; Weng R; Zheng W; Wu Z; Lv Z
Parasitol Res; 2017 Aug; 116(8):2065-2074. PubMed ID: 28664463
[TBL] [Abstract][Full Text] [Related]
6. Of worms, mice and man: an overview of experimental and clinical helminth-based therapy for inflammatory bowel disease.
Heylen M; Ruyssers NE; Gielis EM; Vanhomwegen E; Pelckmans PA; Moreels TG; De Man JG; De Winter BY
Pharmacol Ther; 2014 Aug; 143(2):153-67. PubMed ID: 24603369
[TBL] [Abstract][Full Text] [Related]
7. Helminthic therapy: using worms to treat immune-mediated disease.
Elliott DE; Weinstock JV
Adv Exp Med Biol; 2009; 666():157-66. PubMed ID: 20054982
[TBL] [Abstract][Full Text] [Related]
8. Immunomodulation and Immune Escape Strategies of Gastrointestinal Helminths and Schistosomes.
Wiedemann M; Voehringer D
Front Immunol; 2020; 11():572865. PubMed ID: 33042153
[TBL] [Abstract][Full Text] [Related]
9. Helminth Immunomodulation in Autoimmune Disease.
Smallwood TB; Giacomin PR; Loukas A; Mulvenna JP; Clark RJ; Miles JJ
Front Immunol; 2017; 8():453. PubMed ID: 28484453
[TBL] [Abstract][Full Text] [Related]
10. The hookworm pharmacopoeia for inflammatory diseases.
Navarro S; Ferreira I; Loukas A
Int J Parasitol; 2013 Mar; 43(3-4):225-31. PubMed ID: 23220091
[TBL] [Abstract][Full Text] [Related]
11. Filarial nematode secreted product ES-62 is an anti-inflammatory agent: therapeutic potential of small molecule derivatives and ES-62 peptide mimetics.
Harnett W; Harnett MM
Clin Exp Pharmacol Physiol; 2006; 33(5-6):511-8. PubMed ID: 16700887
[TBL] [Abstract][Full Text] [Related]
12. Helminth immunoregulation: the role of parasite secreted proteins in modulating host immunity.
Hewitson JP; Grainger JR; Maizels RM
Mol Biochem Parasitol; 2009 Sep; 167(1):1-11. PubMed ID: 19406170
[TBL] [Abstract][Full Text] [Related]
13. Can helminths or helminth-derived products be used in humans to prevent or treat allergic diseases?
Erb KJ
Trends Immunol; 2009 Feb; 30(2):75-82. PubMed ID: 19138565
[TBL] [Abstract][Full Text] [Related]
14. The Untapped Pharmacopeic Potential of Helminths.
Kahl J; Brattig N; Liebau E
Trends Parasitol; 2018 Oct; 34(10):828-842. PubMed ID: 29954660
[TBL] [Abstract][Full Text] [Related]
15. Immunomodulation by helminth parasites: defining mechanisms and mediators.
McSorley HJ; Hewitson JP; Maizels RM
Int J Parasitol; 2013 Mar; 43(3-4):301-10. PubMed ID: 23291463
[TBL] [Abstract][Full Text] [Related]
16. Interaction Between Helminths and Toll-Like Receptors: Possibilities and Potentials for Asthma Therapy.
Zakeri A; Borji H; Haghparast A
Int Rev Immunol; 2016 May; 35(3):219-48. PubMed ID: 27120222
[TBL] [Abstract][Full Text] [Related]
17. Do We Need Worms to Promote Immune Health?
Weinstock JV
Clin Rev Allergy Immunol; 2015 Oct; 49(2):227-31. PubMed ID: 25326880
[TBL] [Abstract][Full Text] [Related]
18. Identifying the immunomodulatory components of helminths.
Shepherd C; Navarro S; Wangchuk P; Wilson D; Daly NL; Loukas A
Parasite Immunol; 2015 Jun; 37(6):293-303. PubMed ID: 25854639
[TBL] [Abstract][Full Text] [Related]
19. Novel Therapeutics for Multiple Sclerosis Designed by Parasitic Worms.
Dixit A; Tanaka A; Greer JM; Donnelly S
Int J Mol Sci; 2017 Oct; 18(10):. PubMed ID: 29027962
[TBL] [Abstract][Full Text] [Related]
20. The helminth parasite proteome at the host-parasite interface - Informing diagnosis and control.
van der Ree AM; Mutapi F
Exp Parasitol; 2015 Oct; 157():48-58. PubMed ID: 26116863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
